Parkside Financial Bank & Trust
BankPosition in BTAI — BioXcel Therapeutics, Inc.
CIK 1455267
SAINT LOUIS, MO
Position in BTAI
as of Jun 30, 2026
· filed Sep 4, 2026
Position Value
$157
+$7 QoQ
Shares Held
112
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 47 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Parkside Financial Bank & Trust holds $777,733 across 32 Drug Manufacturers - Specialty & Generic names. BTAI ranks #31 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
12,186 | $193,513 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
1,132 | $125,583 | |
| 3 | ZTS |
Zoetis Inc.
|
1,434 | $103,046 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
131 | $70,979 | |
| 5 | HLN |
Haleon plc
|
6,233 | $58,153 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,702 | $43,313 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,718 | $42,279 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
137 | $23,089 |
All Filings in BTAI
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $157 | 112 | Shares | Sole | 2026-09-04 | |
| 2026-03-31 | $150 | 112 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $179 | 112 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $286 | 112 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $202 | 112 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $227 | 112 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $673 | 1,800 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,098 | 1,800 | Shares | Sole | 2024-11-07 | |
| No filing history on record for this holder in this stock. | ||||||